RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Amyloid precursor protein processing links female urgency urinary incontinence with Alzheimer's disease
Implications for Treatment
Post, W. M., Widomska, J., Oosterwijk, E., De Witte, W., Tiemessen, D. M., Klemann, C. J. H. M., Ruisch, I. H., Coenen, M. J. H., Janssen, D. A. W., Martens, F., Carnes, M. U., Marks, J. A., Page, G. P., Richter, H. E., Cartwright, R., Minassian, V. A., Thomas, L. F., Skogholt, A. H., Stafne, S. N., ... Poelmans, G. (2026). Amyloid precursor protein processing links female urgency urinary incontinence with Alzheimer's disease: Implications for Treatment. International Journal of Molecular Sciences, 27(14), Article 6156. https://doi.org/10.3390/ijms27146156
Urgency urinary incontinence (UUI) and Alzheimer's disease (AD) are highly comorbid conditions in women, but the underlying molecular mechanisms are largely unknown. Therefore, we used network enrichment analyses and an elaborate literature search to integrate the most significant genes from four genome-wide association studies (GWASs) and other genetic, expression and functional evidence into a molecular landscape of female UUI. This molecular landscape centers around local, i.e., bladder-based, processing of the AD-associated amyloid precursor protein (APP). To further elucidate how APP processing is implicated in the comorbidity between UUI and AD, we conducted polygenic risk score (PRS)-based analyses, which showed that genetic risk factors associated with AD and a decreased amyloid beta 42/40 blood level ratio (also) contribute to UUI susceptibility. In conclusion, APP processing constitutes a putative molecular link between UUI and AD, adding further weight to their clinical comorbidity and having implications for the treatment (and prevention) of both traits.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.